Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world data from its ADHD product, Jornay PM (methylphenidate HCl), a central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback